[Local treatment of inflammatory changes in oral cavity with the new Dontisolon M].
Rahn
R
R
Zentrum der Zahn-, Mund- und Kieferheilkunde, Universität Frankfurt.
Frank
P
P
D000890:Anti-Infective Agents / Q000627:therapeutic use*; D004338:Drug Combinations; D010450:Endopeptidases / Q000627:therapeutic use*; D006801:Humans; D009355:Neomycin / Q000627:therapeutic use*; D010497:Pericoronitis / Q000188:drug therapy*; D010518:Periodontitis / Q000188:drug therapy*; D011239:Prednisolone / Q000627:therapeutic use*; D011671:Pulpitis / Q000188:drug therapy*; D013280:Stomatitis / Q000188:drug therapy*; D014100:Toothpastes; D014508:Urea / Q000031:analogs & derivatives* / Q000627:therapeutic use
D000890:Anti-Infective Agents; D004338:Drug Combinations; D014100:Toothpastes; C001122:neomycin, prednisolone, surfen, trypsin-chymotrypsin drug combination; D014508:Urea; D011239:Prednisolone; D010450:Endopeptidases; D009355:Neomycin
Lokale Behandlung entzündlicher Veränderungen der Mundhöhle mit dem neuen Dontisolon M.